MENU
+Compare
IART
Stock ticker: NASDAQ
AS OF
Dec 18, 10:45 AM (EDT)
Price
$23.23
Change
+$0.20 (+0.87%)
Capitalization
2.77B

IART Integra LifeSciences Holdings Corp Forecast, Technical & Fundamental Analysis

a manufacturer of medical devices, implants and biomaterials

IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for IART with price predictions
Dec 17, 2024

IART in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 17, 2024

IART may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 47 cases where IART's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IART advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 182 cases where IART Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IART moved out of overbought territory on November 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IART as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IART turned negative on November 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IART declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IART’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.709) is normal, around the industry mean (23.300). P/E Ratio (41.298) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.876) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IART is expected to report earnings to rise 108.49% to 85 cents per share on February 19

Integra LifeSciences Holdings Corp IART Stock Earnings Reports
Q4'24
Est.
$0.85
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$0.55
Q4'23
Missed
by $0.01
The last earnings report on November 04 showed earnings per share of 40 cents, beating the estimate of 38 cents. With 5.76K shares outstanding, the current market capitalization sits at 2.77B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices, implants and biomaterials

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1100 Campus Road
Phone
+1 609 275-0500
Employees
3946
Web
https://www.integralife.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZGFAX18.010.03
+0.17%
American Beacon Ninety One Gbl Frnchs Y
GIDWX17.32-0.03
-0.17%
Goldman Sachs US Eq Div and Premium R6
JTQRX14.73-0.04
-0.27%
JHancock ESG International Equity R6
HMVRX17.19-0.21
-1.21%
Hartford MidCap Value R3
RMFFX56.22-3.01
-5.07%
American Funds American Mutual R5

IART and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with MASI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
-2.87%
MASI - IART
45%
Loosely correlated
-1.80%
LUNG - IART
40%
Loosely correlated
-1.13%
QDEL - IART
36%
Loosely correlated
-1.85%
DXR - IART
35%
Loosely correlated
-3.33%
AORT - IART
33%
Loosely correlated
-0.21%
More